JPMorgan Issues Coverage on Big Pharma Sector (BMY, LLY, PFE, WYE, MRK, SGP)
June 25, 2008 · Filed Under daily
JPMorgan has come out with a relatively lackluster coverage in the Big Pharma sector, although not all calls are cautious.
Bristol-Myers Squibb (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and Wyeth (NYSE: WYE) were all started in new coverage with “Neutral” ratings.
Merck (NYSE: MRK) and Schering-Plough (NYSE: SGP) were started as “Overweight” in new coverage this morning.
Jon Ogg
June 25, 2008